NAL VON MINDEN NADAL
DEAD

Serial Number

97408852

Owner

nal von minden GmbH

Attorney

Christopher J. Voci

Filing Date

May 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NAL VON MINDEN NADAL Trademark

Serial Number: 97408852

NAL VON MINDEN NADAL is a trademark filed by nal von minden GmbH on May 13, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

nal von minden GmbH (5 trademarks)

Carl-Zeiss-Straße 12

Entity Type: 27

Trademark Details

Filing Date

May 13, 2022

Registration Date

Not Registered

Published for Opposition

April 18, 2023

Goods & Services

Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, allergies, autoimmunity diseases, presence of bacteria, diabetes, blood glucose levels, inflammation, fertility or infertility, pregnancy, sexually transmitted diseases, urinary tract infections, cancer, hormonal disorders, immune status, presence of fungi, presence of viral markers, infectious diseases, food intolerances, HIV, ovulation, myocardial infarction, kidney dysfunction, liver dysfunction, thyroid gland dysfunction, cardiovascular dysfunction, or metabolic dysfunction; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Immunoassay reagents for medical use; Medical diagnostic test media in the form of test strips for measuring the presence of allergy markers, autoimmunity markers, bacteria, fungi, viral markers, diabetes markers, inflammation markers, fertility hormones, pregnancy hormones, fertility markers, markers for sexually transmitted diseases, markers for urinary tract infections, markers for infectious diseases, endocrinology markers, metabolic markers, tumor markers, hormones, blood markers, markers for food intolerances, markers for kidney dysfunction, markers for liver dysfunction, markers for thyroid gland dysfunction, markers for cardiovascular dysfunction, markers for metabolic dysfunction, immune status, urine, or blood glucose levels; Medical diagnostic test media in the form of test strips, test cassettes, multi-line tests, test liquids, ELISA tests, enzyme immunoassays (EIA), and dry chemistry assay for measuring the presence of infectious diseases; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Veterinary diagnostic reagents

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 14, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 14, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 21, 2024 EX3G
SOU EXTENSION 3 FILED
Nov 21, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 21, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 13, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 13, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 12, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 12, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 12, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 13, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2022 NWOS
NEW APPLICATION ENTERED
May 17, 2022 NWAP